The epidemiology of chronic fatigue in San Francisco (Q39478235)

12 September 2017

The epidemiology of chronic fatigue in San Francisco (English)

1 reference

12 September 2017

0 references

1 reference

L Steele

1

1 reference

12 September 2017

J G Dobbins

2

1 reference

12 September 2017

K Fukuda

3

1 reference

12 September 2017

M Reyes

4

1 reference

12 September 2017

B Randall

5

1 reference

12 September 2017

M Koppelman

6

1 reference

12 September 2017

W C Reeves

7

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 September 1998

1 reference

American Journal of Medicine

12 September 2017

1 reference

12 September 2017

105

1 reference

12 September 2017

3A

1 reference

12 September 2017

83S-90S

1 reference

The epidemiology of chronic fatigue syndrome

12 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900158-2

Chronic fatigue, chronic fatigue syndrome, and fibromyalgia. Disability and health-care use

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900158-2

The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900158-2

Seroepidemiology of chronic fatigue syndrome: a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900158-2

Enteroviruses and the chronic fatigue syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900158-2

Lymphocyte subsets, apoptosis, and cytokines in patients with chronic fatigue syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900158-2

Clinical laboratory test findings in patients with chronic fatigue syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900158-2

Lymphocyte phenotype and function in the chronic fatigue syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900158-2

Chronic fatigue syndrome: clinical condition associated with immune activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900158-2

Cell-mediated immunity in patients with chronic fatigue syndrome, healthy control subjects and patients with major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900158-2

Care denied: US residents who are unable to obtain needed medical services.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900158-2

Chronic fatigue and the chronic fatigue syndrome: prevalence in a Pacific Northwest health care system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900158-2

Chronic fatigue syndrome in the community. Prevalence and associations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900158-2

Mania and recovery from chronic fatigue syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900158-2

Chronic fatigue syndrome: have flawed assumptions been derived from treatment-based studies?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900158-2

The epidemiology of fatigue: more questions than answers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900158-2

Psychiatric disorders and medical care utilization among people in the general population who report fatigue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900158-2

Chronic fatigue syndrome: a working case definition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900158-2

NIH conference. Chronic fatigue syndrome research. Definition and medical outcome assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900158-2

Estimating rates of chronic fatigue syndrome from a community-based sample: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900158-2

Fatiguing illness among employees in three large state office buildings, California, 1993: was there an outbreak?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900158-2

Epidemic neuromyasthenia; clinical syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900158-2

Can the chronic fatigue syndrome be defined by distinct clinical features?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900158-2

Chronic fatigue in primary care attenders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900158-2

Patients with fatigue in general practice: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900158-2

The low yield of physical examinations and laboratory investigations of patients with chronic fatigue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900158-2

Usefulness of a standard battery of laboratory tests in investigating chronic fatigue in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900158-2

Chronic fatigue in primary care. Prevalence, patient characteristics, and outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900158-2

Culture and somatic experience: the social course of illness in neurasthenia and chronic fatigue syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900158-2

10.1016/S0002-9343(98)00158-2

7 January 2021

Identifiers

DOI

1 reference

12 September 2017

1 reference